Acanthosis Nigricans in a Patient with Urothelial Carcinoma Treated with PD-L1 Inhibitor Avelumab, and Secondary Adrenal Insufficiency

Acanthosis nigricans (AN) describes hyperkeratotic and hyperpigmented skin changes and its pathophysiology is linked to the activation of epidermal growth factor receptors. Current literature shows that AN is most commonly diagnosed at the time of the underlying pathology, which may occur under beni...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Fei Ya, Jordan, Emmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601793/
https://www.ncbi.nlm.nih.gov/pubmed/37900822
http://dx.doi.org/10.1159/000533758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601793/
https://www.ncbi.nlm.nih.gov/pubmed/37900822
http://dx.doi.org/10.1159/000533758

Ejemplares similares